These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

214 related items for PubMed ID: 3965930

  • 21. Pharmacological and autoradiographic discrimination of sigma and phencyclidine receptor binding sites in brain with (+)-[3H]SKF 10,047, (+)-[3H]-3-[3-hydroxyphenyl]-N-(1-propyl)piperidine and [3H]-1-[1-(2-thienyl)cyclohexyl]piperidine.
    Largent BL, Gundlach AL, Snyder SH.
    J Pharmacol Exp Ther; 1986 Aug; 238(2):739-48. PubMed ID: 3016248
    [Abstract] [Full Text] [Related]

  • 22. Characterization of non-opioid [3H]dynorphin A-(1-13) binding sites in the rat heart.
    Dumont M, Lemaire S.
    J Mol Cell Cardiol; 1993 Aug; 25(8):983-91. PubMed ID: 7903402
    [Abstract] [Full Text] [Related]

  • 23. [3H]Ethylketocyclazocine binding to mouse brain membranes: evidence for a kappa opioid receptor type.
    Garzón J, Sánchez-Blázquez P, Lee NM.
    J Pharmacol Exp Ther; 1984 Oct; 231(1):33-7. PubMed ID: 6092603
    [Abstract] [Full Text] [Related]

  • 24. A novel phencyclidine analog interacts selectively with mu opioid receptors.
    Itzhak Y, Simon EJ.
    J Pharmacol Exp Ther; 1984 Aug; 230(2):383-6. PubMed ID: 6086884
    [Abstract] [Full Text] [Related]

  • 25. Discriminative stimulus properties of (+)- and (-)-n allylnormetazocine: the role of training dose in the stimulus substitution patterns produced by PCP/sigma and mixed action opioid compounds.
    Picker MJ.
    Behav Pharmacol; 1991 Dec; 2(6):497-511. PubMed ID: 11224092
    [Abstract] [Full Text] [Related]

  • 26. High and low affinity psychotomimetic opioid binding sites: characterization by a novel 3H-PCP-analog.
    Itzhak Y.
    NIDA Res Monogr; 1986 Dec; 75():173-6. PubMed ID: 2828967
    [Abstract] [Full Text] [Related]

  • 27. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
    Zhao GM, Qian X, Schiller PW, Szeto HH.
    J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
    [Abstract] [Full Text] [Related]

  • 28. [Specific binding of N-allylnormetazocine (SKF 10047), a ligand of sigma-opioid receptors, with liver membranes].
    Samovilova NN, Iarygin KN, Vinogradov VA.
    Bioorg Khim; 1985 Oct; 11(10):1380-4. PubMed ID: 3000388
    [Abstract] [Full Text] [Related]

  • 29. Selective labeling of serotonin uptake sites in rat brain by [3H]citalopram contrasted to labeling of multiple sites by [3H]imipramine.
    D'Amato RJ, Largent BL, Snowman AM, Snyder SH.
    J Pharmacol Exp Ther; 1987 Jul; 242(1):364-71. PubMed ID: 3475452
    [Abstract] [Full Text] [Related]

  • 30. Adrenal medullary opiate receptors. Pharmacological characterization in bovine adrenal medulla and a human pheochromocytoma.
    Castanas E, Giraud P, Audigier Y, Drissi R, Boudouresque F, Conte-Devolx B, Oliver C.
    Mol Pharmacol; 1984 Jan; 25(1):38-45. PubMed ID: 6323951
    [Abstract] [Full Text] [Related]

  • 31. Binding of [3H]naloxonazine to rat brain membranes.
    Johnson N, Pasternak GW.
    Mol Pharmacol; 1984 Nov; 26(3):477-83. PubMed ID: 6092897
    [Abstract] [Full Text] [Related]

  • 32. Characterization of specific opioid binding sites in neural membranes from the myenteric plexus of porcine small intestine.
    Townsend D, Portoghese PS, Brown DR.
    J Pharmacol Exp Ther; 2004 Jan; 308(1):385-93. PubMed ID: 14569065
    [Abstract] [Full Text] [Related]

  • 33. Central and peripheral cocaine receptors.
    Calligaro DO, Eldefrawi ME.
    J Pharmacol Exp Ther; 1987 Oct; 243(1):61-8. PubMed ID: 2822906
    [Abstract] [Full Text] [Related]

  • 34. Discrimination of three opiate receptor binding sites with the use of a computerized curve-fitting technique.
    Pfeiffer A, Herz A.
    Mol Pharmacol; 1982 Mar; 21(2):266-71. PubMed ID: 6124875
    [Abstract] [Full Text] [Related]

  • 35. Novel diastereomeric opioid tetrapeptides exhibit differing pharmacological activity profiles.
    Ioja E, Tourwé D, Kertész I, Tóth G, Borsodi A, Benyhe S.
    Brain Res Bull; 2007 Sep 14; 74(1-3):119-29. PubMed ID: 17683797
    [Abstract] [Full Text] [Related]

  • 36. Distinct high-affinity binding sites for benzomorphan drugs and enkephalin in a neuroblastoma--brain hybrid cell line.
    McLawhon RW, West RE, Miller RJ, Dawson G.
    Proc Natl Acad Sci U S A; 1981 Jul 14; 78(7):4309-13. PubMed ID: 6117074
    [Abstract] [Full Text] [Related]

  • 37. A comparison between classes of drugs having phencyclidine-like behavioral properties on dopamine efflux in vitro and dopamine metabolism in vivo.
    Snell LD, Mueller ZL, Gannon RL, Silverman PB, Johnson KM.
    J Pharmacol Exp Ther; 1984 Nov 14; 231(2):261-9. PubMed ID: 6092611
    [Abstract] [Full Text] [Related]

  • 38. Characterization and distribution of [3H]ohmefentanyl binding sites in the human brain.
    Wang H, Sarrieau A, Pélaprat D, Roques BP, Vanhove A, Kopp N, Chi ZQ, Rostène W.
    Synapse; 1991 Jul 14; 8(3):177-84. PubMed ID: 1948668
    [Abstract] [Full Text] [Related]

  • 39. [3H]MK-801 labels a site on the N-methyl-D-aspartate receptor channel complex in rat brain membranes.
    Wong EH, Knight AR, Woodruff GN.
    J Neurochem; 1988 Jan 14; 50(1):274-81. PubMed ID: 2826686
    [Abstract] [Full Text] [Related]

  • 40. Anatomical distribution of sodium-dependent [(3)H]naloxone binding sites in rat brain.
    Sim-Selley LJ, Xiao R, Childers SR.
    Synapse; 2000 Mar 15; 35(4):256-64. PubMed ID: 10657035
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.